Cargando…
Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324898/ https://www.ncbi.nlm.nih.gov/pubmed/35891506 http://dx.doi.org/10.3390/v14071526 |
| _version_ | 1784756915235979264 |
|---|---|
| author | Jäger, Niklas Hoffmann, Markus Pöhlmann, Stefan Krüger, Nadine |
| author_facet | Jäger, Niklas Hoffmann, Markus Pöhlmann, Stefan Krüger, Nadine |
| author_sort | Jäger, Niklas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9324898 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93248982022-07-27 Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177 Jäger, Niklas Hoffmann, Markus Pöhlmann, Stefan Krüger, Nadine Viruses Comment MDPI 2022-07-13 /pmc/articles/PMC9324898/ /pubmed/35891506 http://dx.doi.org/10.3390/v14071526 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Comment Jäger, Niklas Hoffmann, Markus Pöhlmann, Stefan Krüger, Nadine Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177 |
| title | Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177 |
| title_full | Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177 |
| title_fullStr | Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177 |
| title_full_unstemmed | Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177 |
| title_short | Nafamostat-Mediated Inhibition of SARS-CoV-2 Ribosomal Frameshifting Is Insufficient to Impair Viral Replication in Vero Cells. Comment on Munshi et al. Identifying Inhibitors of −1 Programmed Ribosomal Frameshifting in a Broad Spectrum of Coronaviruses. Viruses 2022, 14, 177 |
| title_sort | nafamostat-mediated inhibition of sars-cov-2 ribosomal frameshifting is insufficient to impair viral replication in vero cells. comment on munshi et al. identifying inhibitors of −1 programmed ribosomal frameshifting in a broad spectrum of coronaviruses. viruses 2022, 14, 177 |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324898/ https://www.ncbi.nlm.nih.gov/pubmed/35891506 http://dx.doi.org/10.3390/v14071526 |
| work_keys_str_mv | AT jagerniklas nafamostatmediatedinhibitionofsarscov2ribosomalframeshiftingisinsufficienttoimpairviralreplicationinverocellscommentonmunshietalidentifyinginhibitorsof1programmedribosomalframeshiftinginabroadspectrumofcoronavirusesviruses202214177 AT hoffmannmarkus nafamostatmediatedinhibitionofsarscov2ribosomalframeshiftingisinsufficienttoimpairviralreplicationinverocellscommentonmunshietalidentifyinginhibitorsof1programmedribosomalframeshiftinginabroadspectrumofcoronavirusesviruses202214177 AT pohlmannstefan nafamostatmediatedinhibitionofsarscov2ribosomalframeshiftingisinsufficienttoimpairviralreplicationinverocellscommentonmunshietalidentifyinginhibitorsof1programmedribosomalframeshiftinginabroadspectrumofcoronavirusesviruses202214177 AT krugernadine nafamostatmediatedinhibitionofsarscov2ribosomalframeshiftingisinsufficienttoimpairviralreplicationinverocellscommentonmunshietalidentifyinginhibitorsof1programmedribosomalframeshiftinginabroadspectrumofcoronavirusesviruses202214177 |